DexCom, Inc. Revenue 2009–2025
DexCom, Inc. reported $4.66B of revenue for fiscal 2025. That was 15.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +142.0%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $4.66B | +15.6% |
| FY 2024 | $4.03B | +11.3% |
| FY 2023 | $3.62B | +24.5% |
| FY 2022 | $2.91B | +18.8% |
| FY 2021 | $2.45B | +27.1% |
| FY 2020 | $1.93B | +30.5% |
| FY 2019 | $1.48B | +43.1% |
| FY 2018 | $1.03B | +43.6% |
| FY 2017 | $718.50M | +25.3% |
| FY 2016 | $573.30M | +42.6% |
| FY 2015 | $402.00M | +55.1% |
| FY 2014 | $259.20M | +62.0% |
| FY 2013 | $160.00M | +60.2% |
| FY 2012 | $99.90M | +30.9% |
| FY 2011 | $76.30M | +57.0% |
| FY 2010 | $48.60M | +63.7% |
| FY 2009 | $29.69M | — |
Source: DexCom, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open DXCM 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
DexCom, Inc. reported $4.66B of revenue for fiscal 2025. That was 15.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +142.0%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for DexCom, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeDexCom, Inc. — frequently asked questions
What is DexCom, Inc.'s revenue?
DexCom, Inc. (DXCM) reported revenue of $4.66B for fiscal year 2025, per its SEC filings.
How has DexCom, Inc.'s revenue changed over time?
Between fiscal 2009 and 2025, DXCM's revenue grew at roughly 37.2% per year (compound annual rate), from $29.69M to $4.66B.
Where does this data come from?
Figures are computed from DexCom, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.